← United States · Coverage record
US · SEC FORM 4
Theravance Biopharma, Inc.
TBPH · Nasdaq · CIK 0001583107 · Healthcare
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
53 Form 4 transaction lines observed in the same window
11 sales · 42 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 6 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-08-07 · Samaha Eli.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2024-08-07 | Samaha Eli | Purchase (P) | COM | 999,800 | USD 7.80 | USD 7,798,440 | SEC filing ↗ |
| 2024-05-01 | Samaha Eli | Purchase (P) | COM | 1,499,124 | USD 8.75 | USD 13,117,335 | SEC filing ↗ |
Form 4 evidence
82 transaction lines in the latest 365-day window; 381 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | WAM GP LLC; WEISS ANDREW M; Weiss Asset Management LP | J (J) | Ordinary Share $0.00001 Par Value | 7,457,060 | USD 17.00 | USD 126,770,020 | SEC filing ↗ |
| 2026-09-23 | Winningham Rick E | D (D) | Ordinary Shares | 1,726,989 | USD — | USD — | SEC filing ↗ |
| 2026-09-23 | Smaldone Alsup Laurie | D (D) | Ordinary Shares | 80,989 | USD — | USD — | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | WAM GP LLC; WEISS ANDREW M; Weiss Asset Management LP | J (J) | Ordinary Share $0.00001 Par Value | 7,457,060 | USD 17.00 | USD 126,770,020 | SEC filing ↗ |
| 2026-09-23 | Winningham Rick E | D (D) | Ordinary Shares | 1,726,989 | USD — | USD — | SEC filing ↗ |
| 2026-09-23 | Smaldone Alsup Laurie | D (D) | Ordinary Shares | 80,989 | USD — | USD — | SEC filing ↗ |
| 2026-09-23 | Sawaf Aziz | D (D) | Ordinary Shares | 336,841 | USD — | USD — | SEC filing ↗ |
| 2026-09-23 | PAKIANATHAN DEEPIKA | D (D) | Ordinary Shares | 64,074 | USD — | USD — | SEC filing ↗ |
| 2026-09-23 | O'Connor Donal | D (D) | Ordinary Shares | 80,213 | USD — | USD — | SEC filing ↗ |
| 2026-09-23 | Miller Aine | D (D) | Ordinary Shares | 189,826 | USD — | USD — | SEC filing ↗ |
| 2026-09-23 | MITCHELL DEAN J | D (D) | Ordinary Shares | 97,213 | USD — | USD — | SEC filing ↗ |
| 2026-09-23 | Grimaud Brett A. | D (D) | Ordinary Shares | 355,168 | USD — | USD — | SEC filing ↗ |
| 2026-09-23 | GRAY SUSANNAH | D (D) | Ordinary Shares | 48,146 | USD — | USD — | SEC filing ↗ |
| 2026-09-23 | Farnum Rhonda | D (D) | Ordinary Shares | 213,476 | USD — | USD — | SEC filing ↗ |
| 2026-09-15 | Farnum Rhonda | Sale (S) | Ordinary Shares | 13,314 | USD 17.03 | USD 226,737 | SEC filing ↗ |
| 2026-08-20 | Winningham Rick E | Tax withholding (F) | Ordinary Shares | 20,034 | USD 16.95 | USD 339,576 | SEC filing ↗ |
| 2026-08-20 | Sawaf Aziz | Tax withholding (F) | Ordinary Shares | 8,112 | USD 16.95 | USD 137,498 | SEC filing ↗ |
| 2026-08-20 | Miller Aine | Tax withholding (F) | Ordinary Shares | 6,258 | USD 16.95 | USD 106,073 | SEC filing ↗ |
| 2026-08-20 | Grimaud Brett A. | Tax withholding (F) | Ordinary Shares | 7,952 | USD 16.95 | USD 134,786 | SEC filing ↗ |
| 2026-08-20 | Farnum Rhonda | Tax withholding (F) | Ordinary Shares | 5,667 | USD 16.95 | USD 96,056 | SEC filing ↗ |
| 2026-07-07 | Samaha Eli | Sale (S) | COM | 5,564 | USD 17.17 | USD 95,534 | SEC filing ↗ |
| 2026-07-06 | Samaha Eli | Sale (S) | COM | 1,400 | USD 17.04 | USD 23,856 | SEC filing ↗ |
| 2026-07-01 | Samaha Eli | Sale (S) | COM | 37,799 | USD 17.00 | USD 642,583 | SEC filing ↗ |
| 2026-06-30 | Samaha Eli | Sale (S) | COM | 25,027 | USD 17.13 | USD 428,713 | SEC filing ↗ |
| 2026-06-29 | Samaha Eli | Sale (S) | COM | 273,871 | USD 17.23 | USD 4,718,797 | SEC filing ↗ |
| 2026-06-19 | Miller Aine | Award / grant (A) | Ordinary Shares | 18,750 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-15 | Farnum Rhonda | Sale (S) | Ordinary Shares | 13,314 | USD 16.39 | USD 218,183 | SEC filing ↗ |
| 2026-06-12 | Smaldone Alsup Laurie | Award / grant (A) | Ordinary Shares | 6,009 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-12 | PAKIANATHAN DEEPIKA | Award / grant (A) | Ordinary Shares | 6,009 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-12 | O'Connor Donal | Award / grant (A) | Ordinary Shares | 6,009 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-12 | MITCHELL DEAN J | Award / grant (A) | Ordinary Shares | 6,009 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-12 | GRAY SUSANNAH | Award / grant (A) | Ordinary Shares | 6,009 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-20 | Winningham Rick E | Tax withholding (F) | Ordinary Shares | 20,038 | USD 16.55 | USD 331,629 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | TBPH |
| CIK | 0001583107 |
| Sector | Healthcare |
| Industry | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 381 transaction lines from 2020-02-03 to 2026-09-23 3 P purchase lines · 60 S sale lines · 318 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.